Ionis Pharma’s genetic disease drug succeeds in late-stage study

(Reuters) – Ionis Pharmaceuticals said on Monday its therapy for the treatment of a rare genetic disease met the main goal in a late-stage trial.

(Reporting by Sriparna Roy in Bengaluru; Editing by Devika Syamnath)